By | August 31, 2012

Study Links Propecia to Depression

A new study recently published in the Journal of Clinical Psychiatry reports that hair-loss drug finasteride (Propecia) may be linked to more than just permanent sexual side effects. The study found that… Read More

By | July 13, 2012

New study: hair-loss drug Propecia’s side effects may be permanent

As we reported this morning, Propecia has been a topic of interest on the Today Show, and most recently Good Morning America. The Good Morning America segment on ABC discussed the negative side effects of… Read More

By | June 12, 2012

TODAY Reports on Propecia Links to Sexual Dysfunction

This morning the TODAY show reported on a new study that links the hair loss drug Propecia with sexual dysfunction. The study was conducted by Dr. Michael Irwig at George Washington University… Read More

By | June 6, 2012

Actos News and Information Updates for June

The Actos lawyers at the Firm are diligently monitoring information about the type 2 diabetes drug, Actos.  We encourage you to learn more about the serious side effects, risks and legal options… Read More

By | May 15, 2012

FDA Label Requirements Fail Consumers Harmed by Generic Defective Drugs

Generic Drug Manufacturers Should Have a Duty to Warn Consumers of New Safety Concerns Generic drugs account for seventy-five percent of filled prescriptions. Buying generic saves money and, often, the drug is… Read More

By | March 26, 2012

U.S. Regulators Want FDA More Involved with Hip Replacements, Transvaginal Mesh and Other Faulty Medical Devices

Simmons Hanly Conroy is no longer accepting Hip Replacements cases. Bloomberg reports that four Democratic lawmakers, led by Edward Markey of Massachusetts, have issued a bill that would give the FDA the ability… Read More

By | March 19, 2012

Faulty Hip Implants Can Cause Issues Even After Removal

Simmons Hanly Conroy is no longer accepting Hip Replacements cases. A February 2, 2012 article entitled, “Faulty hip implants may cause long-term health, joint damage,” by Janice Lloyd, published on yourlife.usatoday.com, reports… Read More

By | March 6, 2012

Qnexa: Should A Weight Loss Drug with Topamax and Phentermine Get Approval Before Testing? Consumer Reports Weighs In

A ConsumerReports.org article disagrees with experts who recently voted in an overwhelming majority that the Food and Drug Administration should approve the weight loss drug Qnexa and postpone important studies to monitor it for… Read More

By | January 27, 2012

All FDA Committee Members Should Get to Speak Out Regarding Yaz

In a previous blog post, we shared a news story regarding the FDA and the recent Yaz, Yasmin vote that has come under scrutiny. Is the FDA in bed with big pharmaceutical companies?… Read More

By | January 20, 2012

FDA’s Recent Yaz, Yasmin Vote Under Scrutiny

A recent MedPage Today article printed in EveryDay Health* reports that four FDA medical advisors voting on the risks versus benefits of birth control medications, like Yaz and Yasmin, had ties to Bayer. These FDA… Read More

Topics

PAST ARTICLES